0.39
+0(+0.00%)
Currency In USD
| Previous Close | 0.39 |
| Open | 0.37 |
| Day High | 0.4 |
| Day Low | 0.37 |
| 52-Week High | 2.83 |
| 52-Week Low | 0.23 |
| Volume | 764,531 |
| Average Volume | 1.32M |
| Market Cap | 0 |
| PE | -0.27 |
| EPS | -1.46 |
| Moving Average 50 Days | 0.35 |
| Moving Average 200 Days | 0.67 |
| Change | 0 |
If you invested $1000 in Applied Genetic Technologies Corporation (AGTC) 10 years ago, it would be worth $21.78 as of May 10, 2025 at a share price of $0.394. Whereas If you bought $1000 worth of Applied Genetic Technologies Corporation (AGTC) shares 5 years ago, it would be worth $84.46 as of May 10, 2025 at a share price of $0.394.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025
GlobeNewswire Inc.
May 06, 2025 4:00 PM GMT
Data showed improvements across several key measures of visual function, including low luminance visual acuity and microperimetry Laru-zova was generally well-tolerated by DAWN participants at 6 months LONDON and CAMBRIDGE, Mass., May 06, 2025 (GLO